R&G US Inc.

R&G US is an innovative, data focused CRO providing full data services for clinical trial and entire drug life cycle. Founded in February 2019, R&G US has supported the pharmaceutical and biotech companies with a proven record of satisfactorily provided successful regulatory submissions. Led by former FDA expert and industry experts, R&G US can provide end-to-end services in strategic planning, clinical trial design, statistical analysis, and SAS programming. R&G US also provides services to serve as IDMC committee members or as an independent statistical supporting team to provide statistical analysis and reports for IDMC. R&G US has extensive experience to support submissions to FDA, EMA, and PMDA. We are committed to be an accountable partner for our clients providing high-quality services to lower costs, shorten development time, and increase the success probability of drug approval.